Jubilant Life Sciences Ltd. announced on Monday that it has issued Commercial Paper worth Rs 90 crore. The amount raised is going to be used to fund working capital of the company.
The Uttar Pradesh based company stated in its BSE regulatory filing. “Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has issued Commercial Papers (‘CPs’) of Rs. 90 Crore on October 12, 2020.
Details of the same are as follows:
- Issue Size – Rs. 90 Crore
- Listing of Commercial Papers – CPs are proposed to be listed
- Tenure of the instrument – 45 days
- Date of Allotment – 12.10.2020
- Date of Maturity – 26.11.2020
- Coupon/interest offered – 3.88% per annum
- Schedule of payment of interest – Upfront
- Schedule of payment of principal amount – Payment on maturity i.e. November 26, 2020
- Charge/security Unsecured Special right/interest/privileges attached – No Special Rights attached to CPs.”
The aggregate amount of Commercial Papers (including this issue) of the Company outstanding as on date is Rs. 220 Crore.
